Why India should become a global leader in high-quality, affordable TB diagnostics

Indian Journal of Medical Research

Volumn 135, Issue 5, 2012, Pages 685-689

  Small, Peter ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Diagnostics; Generics; India; Innovation; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; GENERIC DRUG; RIFAMPICIN;

HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH PROGRAM; INFECTION CONTROL; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; POINT OF CARE TESTING; REVIEW; SHORT COURSE THERAPY; TUBERCULOSIS;

GOVERNMENT; HUMANS; INDIA; PRIVATE SECTOR; PUBLIC HEALTH; TUBERCULOSIS;

EID: 84863307250     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med 2002; 347: 1420-5.
2. Central TB Division. TB India 2010. RNTCP Status Report. New Delhi, India: Directorate General of Health Services, Ministry of Health and Family Welfare; 2010.
3. World Health Organization. Global tuberculosis control 2010. Geneva: World Health Organization; 2010.
4. Small PM, Pai M. Tuberculosis diagnosis-time for a game change. N Engl J Med 2010; 363: 1070-1.
5. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science 2010; 328: 856-61.
6. Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, Lal SS, et al. Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients. Int J Tuberc Lung Dis 2009; 13: 698-704.
7. Small PM. Strengthening laboratory services for today and tomorrow. Int J Tuberc Lung Dis 2008; 12: 1105-9.
8. Specter M. A Deadly Misdiagnosis. Is it possible to save the millions of people who die from TB? New Yorker;15 November 2010. Available from: http://www/newyorker.com/ reporting/2010/11/15/101115fa_fact_specter, accessed on June 4, 2012.
9. Jaroslawski S, Pai M. Why are inaccurate tuberculosis serological tests widely used in the Indian private healthcare sector? A root-cause analysis. J Epi Global Health 2012; 2: 39-50.
10. World Health Organization. Policy statement: Commercial serodiagnostic tests for diagnosis of tuberculosis. Geneva: World Health Organization; 2011.
11. Special Correspondent. "India must lead the way in developing new diagnostic tools for TB". The Hindu 2010, 19 December 2010. Available from: http://www.thehindu.com/news/states/ tamilnadu/article963222.ece. accessed on June 4, 2012.
12. Goodchild M, Sahu S, Wares F, Dewan P, Shukla RS, Chauhan LS, et al. A cost-benefit analysis of scaling up tuberculosis control in India. Int J Tuberc Lung Dis 2011; 15: 358-62.
13. World Bank. World development report 1993: Investing in Health. Washington DC: The World Bank; 1993.
14. World Health Organization. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. Geneva: WHO; 2010.
15. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-15.
16. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Dye C, et al. Epidemiological benefits of moreeffective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 2009; 106: 13980-5.
17. Kunnath-Velayudhan S, Salamon H, Wang HY, Davidow AL, Molina DM, Huynh VT, et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci USA 2010; 107: 14703-8.
18. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 1920-37.
19. Engel N, Kenneth J, Pai M. TB diagnostics in India: from importation and imitation to innovation. Exp Rev Mol Diagn 2012; 12: 21-4.
20. Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, et al. Improving tuberculosis control through public-private collaboration in India: literature review. BMJ 2006; 332: 574-8.
21. Small PM, Katoch VM. India's contribution to global TB control: Innovative & integrated implementation research. Indian J Med Res 2012; 135: 267-9.